SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GARY P GROBBEL who wrote (15683)12/5/2003 1:14:34 PM
From: GARY P GROBBEL  Read Replies (2) of 120415
 
ALRG finally getting some vol..rising revenue, rising profits....very undervalued here at .81/.85...vol 52,000:

B: Allergy Research Group, Inc. Reports Profits For Third Quarter
B: Allergy Research Group, Inc. Reports Profits For Third Quarter 2003

HAYWARD, Calif., Nov 14, 2003 (BUSINESS WIRE) -- Allergy Research Group, Inc.
(OTCBB:ALRG) announced financial results for the third quarter ending September
30, 2003.

ALRG recorded total revenue of $3,326,957 for the quarter, up 11% from 2002. The
increase of $326,032 is primarily due to increased sales to distributors and
increased demand at retail for current and new products.

"Our overall commitment to good health and concern for our customers, coupled
with our excellent brand identification, has continued to have a positive effect
on sales," said Chief Executive Officer and Chairman, Dr. Stephen A. Levine,
Ph.D.

Cost of sales increased $82,404 to $1,898,692 for the quarter ended September
30, 2003, compared to $1,816,288 for the quarter ended September 30, 2002. The
increase in cost of sales corresponds with the increase in sales. Gross profit
margins increased approximately 3.9%, approximating 42.8% for 2003 resulting
from the higher margins associated with retail sales.

During the quarter ended September 30, 2003, the Company recorded net income of
$397,517, as compared to net income of $122,064 for the same period in 2002. The
increase is a reflection of the increase in sales at higher profit margins and
reduced operating expenses. Interest expense decreased $7,600 for the quarter
ended September 30, 2003, as compared to September 30, 2002 as result of the
Company paying down its line of credit from $570,064 at December 31, 2001 to
zero at September 30, 2003.

Complete copies of the company's financial statements, including notes to the
financials, can be found on its website at www.nutricology.com.

About Allergy Research Group, Inc.

Allergy Research Group, Inc. is an innovative leader in nutraceutical research
and product formulation. Since its inception in 1979, the company has been noted
for quality, hypoallergenic nutritional supplements and supplies products to
physicians and healthcare practitioners worldwide.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext